Market Trends– category –
-
BioCraft Pet Nutrition Releases Cultivated Meat Safety Dossier, Urging Industry Transparency
The Spoon USA Overview BioCraft Pet Nutrition publicly released its safety dossier for cultivated meat, urging other companies to follow suit for regulatory clarity and increased industry transparency. The dossier details years of safety... -
Japan Prioritizes Quality in ‘China Plus One’ CDMO Strategy with Over $4 Billion Investment by FUJIFILM Diosynth and Others
BioProcess International USA Overview A BioProcess International article analyzes the 'China Plus One' strategy and biomanufacturing capacity in the APAC region. FUJIFILM Diosynth Biotechnologies has committed over $4 billion to global e... -
APAC’s Bioprocessing Technology Ready, Regulatory Certainty Needed for Continuous Manufacturing Investment; China/Korea CDMOs Lead Adoption
BioProcess International USA Overview A BioProcess International article analyzes regulatory challenges for continuous and intensified bioprocessing adoption in the Asia Pacific (APAC) region. While hardware and software for perfusion bi... -
MDPI Review Highlights Urgent Need for Cost-Effective, Sustainable Serum-Free Media to Enable Cultivated Meat Production
MDPI Global Overview A new MDPI review emphasizes that developing cost-effective and sustainable serum-free media is crucial for the commercial viability of cultivated meat and seafood, as media formulations currently account for 55–95% ... -
Green Elephant Biotech Highlights 74% Cost Reduction Potential and Accelerated Development in Cell & Gene Therapy Through Automation
Green Elephant Biotech Germany Overview Green Elephant Biotech has highlighted the potential of automation platforms to significantly reduce development timelines and manufacturing costs in cell and gene therapy (CGT). Cases like Multipl... -
Global Pharma and Biotech Firms Intensify Investment in Biologics Contract Manufacturing Market, openPR.com Reports
openPR.com USA Overview Global pharmaceutical and biotechnology companies are significantly increasing their investments in the biologics contract manufacturing (CDMO) market, as reported by openPR.com. FUJIFILM Diosynth Biotechnologies ... -
IEA Global Hydrogen Review 2026: Over 40% of Low-Emissions Hydrogen Projects Reliant on Trade, Infrastructure Development Lags
IEA France Overview The IEA's "Global Hydrogen Review 2026" forecasts that over 40% of low-emissions hydrogen projects will rely on international trade by 2030, highlighting trade as a major driver. Despite plans for over 40,000 km of hy... -
Gridlock Ahead: Energy Transition Market Soars to $3.17 Trillion, Yet Infrastructure Bottlenecks Loom Large
MarketScale World Overview The global energy transition market is projected to reach an impressive $3.17 trillion by 2026, nearly doubling to $5.99 trillion by 2032, driven by large-scale implementation of renewables and hydrogen infrast... -
RMI Report: Hydrogen-DRI and EAF Combination Emerges as Key Path to Near-Zero Emissions Steelmaking, Existing Conversions Cost $150-200M
RMI USA Overview An RMI analysis concludes that the combination of hydrogen-based Direct Reduced Iron (H2-DRI) and Electric Arc Furnaces (EAF) represents the primary commercial pathway to achieving near-zero emissions steelmaking. Howeve... -
The “Hydrogen Mirage”: Green Steel Timelines Slip as High Costs and Slow Electrolyzer Scaling Hinder Commercial Deployment in Europe
Steelonthenet Europe Overview Hydrogen-based green steel, central to Europe's decarbonization strategy, is experiencing significant project delays, exposing challenges in achieving commercial-scale deployment. Major initiatives are falli...
